In line with this, the TCF/LEF transcriptional program, where CHD1L plays a key regulatory role, has been shown to inhibit immune surveillance by excluding T cells from the tumor microenvironment and inducing immune checkpoint gene expression [99]. Here, CHD1L is linked to neoplasm.